Financing, Equity Capital Markets
Fate Therapeutics, Inc.
09/18
|
$143.8 Million
![](/sites/default/files/images/custom/fate-therapeutics-inc.png)
Piper Sandler served as bookrunner for Fate Therapeutics, Inc. on a confidentially marketed follow-on offering